Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines
European Pharmaceutical Review
JUNE 29, 2022
As the healthcare sector grows, there is a clear trend towards the expansion of biologic therapeutic drugs and vaccines like the one developed by Novavax. Any modification in the manufacturing process could drastically impact the structure or the effectiveness of the product for patients, inciting a major public health threat.
Let's personalize your content